UniProt/SwissProt ID: | NOTC2_HUMAN |
Description: | notch 2 [Source:HGNC Symbol;Acc:7882] |
Location: | chr1 p11.2 |
Node attribute: | substrate; receptor; glycosylation(target) |
Phosphorylation site |
Position | PhosphoPeptide | Catalytic kinase | Source |
---|---|---|---|
S1804 | IRRTPsLALTP | PhosphoSitePlus; HPRD; phosphoELM | |
Y2373 | TILPAyHPFPA | PhosphoSitePlus | |
T2068 | DEYNVtPSPPG | GSK3B | HPRD; RegPhos |
S2134 | SRRKKsLSEKV | PhosphoSitePlus | |
T2074 | PSPPGtVLTSA | phosphoELM | |
T2077 | PGTVLtSALSP | HPRD | |
S1854 | EDAEDsSANII | HPRD | |
S1722 | LRRDAsNHKRR | PhosphoSitePlus | |
S1778 | DEALLsEEDDP | PhosphoSitePlus; HPRD; phosphoELM | |
Y2023 | AREGSyEAAKI | HPRD | |
S1708 | KRKHGsLWLPE | 7TMR-DISM_7TM | PhosphoSitePlus |
S1841 | SLRGGsSDLSD | HPRD; phosphoELM; RegPhos | |
T436 | GKCVNtDGAFH | EGF_CA | PhosphoSitePlus |
S1855 | DAEDSsANIIT | HPRD | |
Y2470 | NNMQVyA____ | PhosphoSitePlus | |
S2070 | YNVTPsPPGTV | PhosphoSitePlus; HPRD; phosphoELM; RegPhos | |
T436 | GKCVNtDGAFH | HPRD | |
S1842 | LRGGSsDLSDE | HPRD; RegPhos | |
S2093 | NRSFLsLKHTP | GSK3B | HPRD; RegPhos |
S2129 | KDAKGsRRKKS | PhosphoSitePlus | |
T1808 | PSLALtPPQAE | PhosphoSitePlus; HPRD; phosphoELM; RegPhos | |
S1845 | GSSDLsDEDED | PhosphoSitePlus; HPRD; phosphoELM; RegPhos | |
S2078 | GTVLTsALSPV | HPRD; RegPhos | |
T2296 | GKHITtPREPL | PhosphoSitePlus; HPRD; phosphoELM | |
T2295 | EGKHItTPREP | HPRD | |
S2081 | LTSALsPVICG | PhosphoSitePlus; HPRD; phosphoELM | |
T1716 | LPEGFtLRRDA | PhosphoSitePlus; HPRD; phosphoELM | |
T1802 | ADIRRtPSLAL | PhosphoSitePlus; HPRD; phosphoELM | |
S1670 | SVVSEsLTPER | NODP; 7TMR-DISM_7TM | PhosphoSitePlus |
S2136 | RKKSLsEKVQL | PhosphoSitePlus | |
T2097 | LSLKHtPMGKK | PhosphoSitePlus; HPRD; phosphoELM | |
T2074 | PSPPGtVLTSA | GSK3B | HPRD; RegPhos |
S2070 | YNVTPsPPGTV | GSK3B | HPRD; RegPhos |
Dephosphorylation site |
NOTC2_HUMAN do not have dephosphorylation site. |
Mutation site |
Ensembl ID | Variation | Source | Cancer name | Pubmed |
---|---|---|---|---|
ENSP00000256646 | G488D | COSMIC | Skin Cancer | 21984974 |
ENSP00000256646 | D2125N | BIOMART | Pancreatic Cancer | 21930507, 21930502 |
ENSP00000256646 | E297K | COSMIC | Skin Cancer | 21984974 |
ENSP00000256646 | C19W | COSMIC | Central Nervous System Neoplasms | 21817013 |
ENSP00000256646 | R1931H | COSMIC | Ovarian Cancer | 21720365 |
ENSP00000256646 | P2289fs*6 | COSMIC | Lymphoma | 19445024 |
ENSP00000256646 | P2343S | COSMIC | Skin Cancer | 22006338 |
ENSP00000256646 | H1638Y | COSMIC | Lymphoma | 18508802 |
ENSP00000256646 | P224L | COSMIC | Skin Cancer | 21984974 |
ENSP00000256646 | Y790C | COSMIC | Ovarian Cancer | 21720365 |
ENSP00000256646 | S2394F | COSMIC | Lung Cancer | 20668451 |
ENSP00000256646 | Q1584* | COSMIC | Lung Cancer | |
ENSP00000256646 | P1913S | COSMIC | Skin Cancer | 22006338 |
ENSP00000256646 | E850* | COSMIC | Head and Neck Cancer | 21798893 |
ENSP00000256646 | Q1616* | COSMIC | Skin Cancer | 21984974 |
ENSP00000256646 | N46S | COSMIC | Skin Cancer | 22006338 |
ENSP00000256646 | M1879I | COSMIC | Lung Cancer | 20668451 |
ENSP00000256646 | Q1634* | COSMIC | Skin Cancer | 21984974 |
ENSP00000256646 | Q1392* | COSMIC | Lung Cancer | 22006338 |
ENSP00000256646 | Y857C | COSMIC | Head and Neck Cancer | 21798893 |
ENSP00000256646 | R1630L | COSMIC | Lung Cancer | 20668451 |
ENSP00000256646 | C616F | COSMIC | Skin Cancer | 22006338 |
ENSP00000256646 | S2222I | Ding2008, COSMIC | Lung Cancer | 18948947 |
ENSP00000256646 | D1733Y | COSMIC | Lung Cancer | 22006338 |
ENSP00000256646 | R2105Q | COSMIC | Head and Neck Cancer | 21798893 |
ENSP00000256646 | C861Y | COSMIC | Skin Cancer | 22006338 |
ENSP00000256646 | R2453Q | COSMIC | Lymphoma | 19445024 |
ENSP00000256646 | H1512Y | COSMIC | Melanoma | 21499247 |
ENSP00000256646 | S1888* | COSMIC | Lung Cancer | |
ENSP00000256646 | G1751D | COSMIC | Skin Cancer | 22006338 |
ENSP00000256646 | A1806T | COSMIC | Lung Cancer | 20668451 |
ENSP00000256646 | S1836F | COSMIC | Skin Cancer | 21984974 |
ENSP00000256646 | E38K | COSMIC | Skin Cancer | 22006338 |
ENSP00000256646 | R1048C | COSMIC | Renal Cancer | 20054297 |
ENSP00000256646 | D1451N | COSMIC | Skin Cancer | 22006338 |
ENSP00000256646 | R2400* | COSMIC | Lymphoma | 19445024 |
ENSP00000256646 | V721L | COSMIC | Head and Neck Cancer | 21798893 |
ENSP00000256646 | S2388L | COSMIC | Lung Cancer | 20668451 |
ENSP00000256646 | A1340S | COSMIC | Ovarian Cancer | 21720365 |
ENSP00000256646 | T2278I | COSMIC | Skin Cancer | 21984974 |
ENSP00000256646 | R1838* | COSMIC | Skin Cancer | 21984974 |
ENSP00000256646 | G313C | COSMIC | Skin Cancer | 21984974 |
ENSP00000256646 | K1514R | BIOMART | Breast Cancer | 21930507, 21930502 |
ENSP00000256646 | C433Y | COSMIC | Skin Cancer | 22006338 |
ENSP00000256646 | W330* | COSMIC | Skin Cancer | 21984974 |
ENSP00000256646 | G601C | COSMIC | Central Nervous System Neoplasms | 18772396 |
ENSP00000256646 | K758R | COSMIC | Prostate Cancer | 20668451 |
ENSP00000256646 | R452C | COSMIC | Skin Cancer | 21984974 |
ENSP00000256646 | V2075M | COSMIC | Renal Cancer | 20054297 |
ENSP00000256646 | Q2341* | COSMIC | Lymphoma | 18508802 |
Differential expressed protein |
Ensembl ID | Cancer name | Design | Sample | Change | Ratio | Pubmed |
---|---|---|---|---|---|---|
ENSP00000256646 | Testicular Cancer | Normal vs. Cancer | cell line | Up | 18489135 | |
Hyperphosphorylation site |
NOTC2_HUMAN do not have hyperphosphorylation site. |
Direct Interaction Pair |
Source | Target | Relationship | Resource |
---|---|---|---|
JAG1_HUMAN | NOTC2_HUMAN | ligand -> receptor | HPMR |
ZAGL2_HUMAN | NOTC2_HUMAN | kinase -> substrate | RegPhos |
GSK3B_HUMAN | NOTC2_HUMAN | kinase -> substrate | RegPhos; NetPath |
LFNG_HUMAN | NOTC2_HUMAN | glycosylation | NetPath |
MFNG_HUMAN | NOTC2_HUMAN | glycosylation | NetPath |
Function Annotation |
KEGG Pathway |
KEGG ID | Pathway |
---|---|
hsa04320 | Dorso-ventral axis formation |
hsa04330 | Notch signaling pathway |
Gene Ontology |
GO ID | GO_Term | Evidence | Ontology |
---|---|---|---|
GO:0009887 | organ morphogenesis | IEP | biological_process |
GO:0005886 | plasma membrane | TAS | cellular_component |
GO:0016021 | integral to membrane | IEA | cellular_component |
GO:0046579 | positive regulation of Ras protein signal transduc | IDA | biological_process |
GO:0005515 | protein binding | IPI | molecular_function |
GO:0030154 | cell differentiation | IEA | biological_process |
GO:0006917 | induction of apoptosis | TAS | biological_process |
GO:0007050 | cell cycle arrest | IDA | biological_process |
GO:0003184 | pulmonary valve morphogenesis | IMP | biological_process |
GO:0061314 | Notch signaling involved in heart development | IC | biological_process |
GO:0006355 | regulation of transcription, DNA-dependent | TAS | biological_process |
GO:0005789 | endoplasmic reticulum membrane | TAS | cellular_component |
GO:0001890 | placenta development | IEA | biological_process |
GO:0005887 | integral to plasma membrane | IDA | cellular_component |
GO:0016049 | cell growth | IDA | biological_process |
GO:0000139 | Golgi membrane | TAS | cellular_component |
GO:0010467 | gene expression | TAS | biological_process |
GO:0005576 | extracellular region | TAS | cellular_component |
GO:0030326 | embryonic limb morphogenesis | IEA | biological_process |
GO:0001701 | in utero embryonic development | IEA | biological_process |
GO:0030097 | hemopoiesis | TAS | biological_process |
GO:0002011 | morphogenesis of an epithelial sheet | IEA | biological_process |
GO:0007219 | Notch signaling pathway | TAS | biological_process |
GO:0043066 | negative regulation of apoptotic process | TAS | biological_process |
GO:0060674 | placenta blood vessel development | IEA | biological_process |
GO:0005654 | nucleoplasm | TAS | cellular_component |
GO:0050793 | regulation of developmental process | IEA | biological_process |
GO:0072602 | interleukin-4 secretion | IEA | biological_process |
GO:0060413 | atrial septum morphogenesis | IMP | biological_process |
GO:0007220 | Notch receptor processing | TAS | biological_process |
GO:0004872 | receptor activity | NAS | molecular_function |
GO:0005634 | nucleus | IDA | cellular_component |
GO:0006367 | transcription initiation from RNA polymerase II pr | TAS | biological_process |
GO:0007368 | determination of left/right symmetry | IEA | biological_process |
GO:0016020 | membrane | IEA | cellular_component |
GO:0007399 | nervous system development | NAS | biological_process |
GO:0009986 | cell surface | IDA | cellular_component |
GO:0043065 | positive regulation of apoptotic process | IEA | biological_process |
GO:0005509 | calcium ion binding | IEA | molecular_function |
GO:0008285 | negative regulation of cell proliferation | IDA | biological_process |
GO:0002437 | inflammatory response to antigenic stimulus | IEA | biological_process |
GO:0019827 | stem cell maintenance | TAS | biological_process |
GO:0007275 | multicellular organismal development | NAS | biological_process |
GO:0006959 | humoral immune response | IEA | biological_process |
GO:0001709 | cell fate determination | TAS | biological_process |
GO:0046849 | bone remodeling | IMP | biological_process |